Weight LossNov 11, 2026
Systematic review·Annals of internal medicine

Next-Generation GLP-1 Drugs Show Even Greater Weight Loss

An updated review of nearly 26,000 adults shows emerging multiagonist medications can reduce body weight by nearly a quarter.

Read Analysis
Weight LossNov 4, 2026
Review·Journal of the International Society of Sports Nutrition

What Science Actually Says About Effective Dieting Strategies

The International Society of Sports Nutrition's definitive guidance reveals why protein intake and resistance training beat restrictive diet trends.

Read Analysis
Weight LossNov 4, 2026
RCT·Diabetes, obesity & metabolism

How Semaglutide Alters Muscle Quality and Everyday Physical Function

A new study reveals semaglutide reduces muscle fat infiltration while preserving everyday physical strength.

Read Analysis
Weight LossOct 7, 2026
RCT·Arthritis & rheumatology (Hoboken, N.J.)

Adding Tirzepatide to Arthritis Therapy Delivers Superior Relief

Combining tirzepatide with standard biologic treatment dramatically improves joint pain, skin symptoms, and physical function in psoriatic arthritis.

Read Analysis
Weight LossSep 30, 2026
Meta-analysis·Endocrinology, diabetes & metabolism

Stopping Ozempic or Mounjaro? Study Projects Rapid Weight Regain

New research reveals how quickly patients regain weight after stopping popular GLP-1 medications like Wegovy and Zepbound.

Read Analysis
Weight LossSep 30, 2026
RCT·The American journal of clinical nutrition

How Semaglutide Cuts Calories Even When Hunger Returns

A new 60-week study reveals that semaglutide helps people eat less long-term, even after its subjective appetite-suppressing effects begin to fade.

Read Analysis
Weight LossSep 23, 2026
RCT·Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology

Oral Semaglutide Slashes Liver Fat and Body Weight

A new clinical trial shows oral semaglutide significantly reduces body fat and improves liver health in people without diabetes.

Read Analysis
Weight LossSep 16, 2026
Meta-analysis·Diabetes research and clinical practice

Popular GLP-1 Medications Linked to Higher Hair Loss Risk

A new study reveals a significant link between popular GLP-1 receptor agonists and an increased risk of temporary hair shedding.

Read Analysis
Weight LossSep 9, 2026
RCT·The American journal of psychiatry

Oral Semaglutide Shows Promise in Reducing Heavy Drinking

A new clinical trial suggests the blockbuster drug semaglutide could help people struggling with alcohol use disorder cut back on heavy drinking.

Read Analysis